Patents by Inventor Mike T. Li

Mike T. Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stable compositions comprising tezacitabine
    Publication number: 20030171329
    Abstract: The present invention relates to tezacitabine ((E)-2′-fluoromethylene-2′-deoxycytidine) formulations which are stable for long periods of time. The present invention further relates to methods of formulating stable tezacitabine formulations.
    Type: Application
    Filed: February 12, 2003
    Publication date: September 11, 2003
    Inventors: Richard E. Jones, Mike T. Li, Andy Trammel, Christine M. Harrison-Bowman, Kimberly R. Shirley
  • Collagen formulations
    Patent number: 5980946
    Abstract: Disclosed are proteinaceous compositions comprising collagen and an effective amount of a compatible cytotoxic drug which compositions are characterized by having a single collagen transition temperature of less than about 45.degree. C. Such compositions possess enhanced retention of the cytotoxic drug at the site of injection and are optically translucent.
    Type: Grant
    Filed: September 3, 1997
    Date of Patent: November 9, 1999
    Assignee: Matrix Pharmaceutical, Inc.
    Inventors: Richard E. Jones, Mike T. Li
  • Translucent collagen formulations with a cytotoxic drug
    Patent number: 5750146
    Abstract: Disclosed are translucent proteinaceous compositions comprising collagen and an effective amount of a compatible cytotoxic drug which compositions are characterized by having a single collagen transition temperature of less than about 45.degree. C. Such compositions possess enhanced retention of the cytotoxic drug at the site of injection and are optically translucent.
    Type: Grant
    Filed: April 28, 1995
    Date of Patent: May 12, 1998
    Assignee: Matrix Pharmaceutical, Inc.
    Inventors: Richard E. Jones, Mike T. Li